Epix buoyed by MRA (magnetic resonance angiography) contrast data
This article was originally published in Clinica
Executive Summary
The second pivotal trial of Epix Medical's magnetic resonance angiography (MRA) contrast agent for detecting vascular disease has produced yet further evidence to support international marketing applications for the product.